Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma

Background Malignant mesothelioma (MM) is a rare and highly aggressive cancer. Despite advances in multidisciplinary treatments for cancer, the prognosis for MM remains poor with no effective diagnostic biomarkers currently available. The aim of this study was to identify plasma metabolic biomarkers...

Full description

Bibliographic Details
Main Authors: Yun Gao, Ziyi Dai, Chenxi Yang, Ding Wang, Zhenying Guo, Weimin Mao, Zhongjian Chen
Format: Article
Language:English
Published: PeerJ Inc. 2022-01-01
Series:PeerJ
Subjects:
Online Access:https://peerj.com/articles/12568.pdf
_version_ 1797418438485868544
author Yun Gao
Ziyi Dai
Chenxi Yang
Ding Wang
Zhenying Guo
Weimin Mao
Zhongjian Chen
author_facet Yun Gao
Ziyi Dai
Chenxi Yang
Ding Wang
Zhenying Guo
Weimin Mao
Zhongjian Chen
author_sort Yun Gao
collection DOAJ
description Background Malignant mesothelioma (MM) is a rare and highly aggressive cancer. Despite advances in multidisciplinary treatments for cancer, the prognosis for MM remains poor with no effective diagnostic biomarkers currently available. The aim of this study was to identify plasma metabolic biomarkers for better MM diagnosis and prognosis by use of a MM cell line-derived xenograft (CDX) model. Methods The MM CDX model was confirmed by hematoxylin and eosin staining and immunohistochemistry. Twenty female nude mice were randomly divided into two groups, 10 for the MM CDX model and 10 controls. Plasma samples were collected two weeks after tumor cell implantation. Gas chromatography-mass spectrometry analysis was conducted. Both univariate and multivariate statistics were used to select potential metabolic biomarkers. Hierarchical clustering analysis, metabolic pathway analysis, and receiver operating characteristic (ROC) analysis were performed. Additionally, bioinformatics analysis was used to investigate differential genes between tumor and normal tissues, and survival-associated genes. Results The MM CDX model was successfully established. With VIP > 1.0 and P-value < 0.05, a total of 23 differential metabolites were annotated, in which isoleucine, 5-dihydrocortisol, and indole-3-acetamide had the highest diagnostic values based on ROC analysis. These were mainly enriched in pathways for starch and sucrose metabolism, pentose and glucuronate interconversions, galactose metabolism, steroid hormone biosynthesis, as well as phenylalanine, tyrosine and tryptophan biosynthesis. Further, down-regulation was observed for amino acids, especially isoleucine, which is consistent with up-regulation of amino acid transporter genes SLC7A5 and SLC1A3 in MM. Overall survival was also negatively associated with SLC1A5, SLC7A5, and SLC1A3. Conclusion We found several altered plasma metabolites in the MM CDX model. The importance of specific metabolic pathways, for example amino acid metabolism, is herein highlighted, although further investigation is warranted.
first_indexed 2024-03-09T06:32:39Z
format Article
id doaj.art-0f379346687747ef90647665557938f8
institution Directory Open Access Journal
issn 2167-8359
language English
last_indexed 2024-03-09T06:32:39Z
publishDate 2022-01-01
publisher PeerJ Inc.
record_format Article
series PeerJ
spelling doaj.art-0f379346687747ef90647665557938f82023-12-03T11:02:17ZengPeerJ Inc.PeerJ2167-83592022-01-0110e1256810.7717/peerj.12568Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesotheliomaYun Gao0Ziyi Dai1Chenxi Yang2Ding Wang3Zhenying Guo4Weimin Mao5Zhongjian Chen6The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, ChinaThe Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, ChinaThe Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, ChinaThe Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, ChinaThe Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, ChinaThe Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, ChinaThe Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Hangzhou, ChinaBackground Malignant mesothelioma (MM) is a rare and highly aggressive cancer. Despite advances in multidisciplinary treatments for cancer, the prognosis for MM remains poor with no effective diagnostic biomarkers currently available. The aim of this study was to identify plasma metabolic biomarkers for better MM diagnosis and prognosis by use of a MM cell line-derived xenograft (CDX) model. Methods The MM CDX model was confirmed by hematoxylin and eosin staining and immunohistochemistry. Twenty female nude mice were randomly divided into two groups, 10 for the MM CDX model and 10 controls. Plasma samples were collected two weeks after tumor cell implantation. Gas chromatography-mass spectrometry analysis was conducted. Both univariate and multivariate statistics were used to select potential metabolic biomarkers. Hierarchical clustering analysis, metabolic pathway analysis, and receiver operating characteristic (ROC) analysis were performed. Additionally, bioinformatics analysis was used to investigate differential genes between tumor and normal tissues, and survival-associated genes. Results The MM CDX model was successfully established. With VIP > 1.0 and P-value < 0.05, a total of 23 differential metabolites were annotated, in which isoleucine, 5-dihydrocortisol, and indole-3-acetamide had the highest diagnostic values based on ROC analysis. These were mainly enriched in pathways for starch and sucrose metabolism, pentose and glucuronate interconversions, galactose metabolism, steroid hormone biosynthesis, as well as phenylalanine, tyrosine and tryptophan biosynthesis. Further, down-regulation was observed for amino acids, especially isoleucine, which is consistent with up-regulation of amino acid transporter genes SLC7A5 and SLC1A3 in MM. Overall survival was also negatively associated with SLC1A5, SLC7A5, and SLC1A3. Conclusion We found several altered plasma metabolites in the MM CDX model. The importance of specific metabolic pathways, for example amino acid metabolism, is herein highlighted, although further investigation is warranted.https://peerj.com/articles/12568.pdfCell line-derived xenograftGC-MSMalignant mesotheliomaMetabolomicsAmino acid metabolism
spellingShingle Yun Gao
Ziyi Dai
Chenxi Yang
Ding Wang
Zhenying Guo
Weimin Mao
Zhongjian Chen
Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
PeerJ
Cell line-derived xenograft
GC-MS
Malignant mesothelioma
Metabolomics
Amino acid metabolism
title Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
title_full Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
title_fullStr Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
title_full_unstemmed Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
title_short Metabolomics of a cell line-derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
title_sort metabolomics of a cell line derived xenograft model reveals circulating metabolic signatures for malignant mesothelioma
topic Cell line-derived xenograft
GC-MS
Malignant mesothelioma
Metabolomics
Amino acid metabolism
url https://peerj.com/articles/12568.pdf
work_keys_str_mv AT yungao metabolomicsofacelllinederivedxenograftmodelrevealscirculatingmetabolicsignaturesformalignantmesothelioma
AT ziyidai metabolomicsofacelllinederivedxenograftmodelrevealscirculatingmetabolicsignaturesformalignantmesothelioma
AT chenxiyang metabolomicsofacelllinederivedxenograftmodelrevealscirculatingmetabolicsignaturesformalignantmesothelioma
AT dingwang metabolomicsofacelllinederivedxenograftmodelrevealscirculatingmetabolicsignaturesformalignantmesothelioma
AT zhenyingguo metabolomicsofacelllinederivedxenograftmodelrevealscirculatingmetabolicsignaturesformalignantmesothelioma
AT weiminmao metabolomicsofacelllinederivedxenograftmodelrevealscirculatingmetabolicsignaturesformalignantmesothelioma
AT zhongjianchen metabolomicsofacelllinederivedxenograftmodelrevealscirculatingmetabolicsignaturesformalignantmesothelioma